Companies/CN/300765

CSPC INNOVATION PHARMACEUTICAL CO., LTD. · 新诺威

Income flow

Annual
300765 10-K Income StatementPeriod 2023-12-31Source 10-K
Net salesCNY 3B-5% Y/YRevenueCNY 3B-5% Y/YGross profitCNY 1BCost of revenueCNY 1BOperating profitCNY 262MOperating expensesCNY 908MNet profitCNY 434MTaxCNY 136MR&D & otherCNY 698MSG&ACNY 211M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · CNY
By activity
By activityCNY 2.2B
  • 功能性原料及保健食品CNY 1.9B86.1%
  • 生物制药CNY 257M11.9%
  • 其他CNY 43M2.0%
By geography
By geographyCNY 2.2B
  • 境内CNY 1.1B51.8%
  • 境外CNY 1.0B48.2%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.17.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).1.40BFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).343.9M
Dividend calendar
Ex-dividend
2025-05-29
Last cash
0.02 · 2025-05-29
Stock splits
  1. 1.2:12024-04-25
  2. 1.8:12023-04-27
  3. 1.3:12021-04-28
  4. 2.1:12020-04-29

Valuation

Trailing PE 96.1 (2023-12-31)PE trend

Fiscal PE1

PeriodEPSClosePE
2023-12-310.3129.8896.1

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.